Mass General Starts Personalized Cancer Program | GenomeWeb

NEW YORK (GenomeWeb News) – The Massachusetts General Hospital Cancer Center plans to begin using gene-based tests for nearly all of its cancer patients to help make treatment decisions as part of a personalized healthcare initiative, it said this week.

The hospital said it will use its newly opened translational research laboratory to support this program, which also is aimed at gathering research data from tumors that may contribute to more personalized treatments in the future.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."